Literature DB >> 27125641

The Selective Use of Combination Therapy in Patients with Inflammatory Bowel Disease Resistant to Anti-TNF: to Whom, How and How Long?

Fabio Salvatore Macaluso1, Mario Cottone2, Ambrogio Orlando2.   

Abstract

Entities:  

Keywords:  Anti-TNF; Crohn’s disease; combination therapy; immunomodulator

Mesh：

Substances：

Year:  2016        PMID： 27125641     DOI： 10.1093/ecco-jcc/jjw089

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  1 in total

1.  The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.

Authors:  A N Ananthakrishnan; A Sakuraba; E L Barnes; J Pekow; L Raffals; M D Long; R S Sandler
Journal:  Aliment Pharmacol Ther       Date:  2017-05-03       Impact factor: 8.171
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.